A cohort based study analysing effectiveness and health care utilization, by age the proportion, of patients with MS treated with subcutaneous interferon beta-1a
Latest Information Update: 06 Jul 2020
At a glance
- Drugs Interferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
Most Recent Events
- 06 Jul 2020 New trial record
- 26 May 2020 Results presented at the 6th Congress of the European Academy of Neurology